Measuring Diagnostic Test Performance Using Imperfect Reference Tests: A Partial Identification Approach
Filip Obradovi\'c

TL;DR
This paper develops a method to estimate the true performance of diagnostic tests when the reference standard is imperfect, providing bounds on sensitivity, specificity, and related parameters using partial identification techniques.
Contribution
It introduces a novel partial identification approach to bound true diagnostic test performance metrics without assuming a perfect reference test.
Findings
Bounds on sensitivity and specificity can be very informative.
Estimated false negative rates are significantly higher than apparent rates.
Method applied to COVID-19 antigen test data demonstrates practical utility.
Abstract
Diagnostic tests are almost never perfect. Studies quantifying their performance use knowledge of the true health status, measured with a reference diagnostic test. Researchers commonly assume that the reference test is perfect, which is often not the case in practice. When the assumption fails, conventional studies identify "apparent" performance or performance with respect to the reference, but not true performance. This paper provides the smallest possible bounds on the measures of true performance - sensitivity (true positive rate) and specificity (true negative rate), or equivalently false positive and negative rates, in standard settings. Implied bounds on policy-relevant parameters are derived: 1) Prevalence in screened populations; 2) Predictive values. Methods for inference based on moment inequalities are used to construct uniformly consistent confidence sets in level over a…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · SARS-CoV-2 detection and testing · COVID-19 epidemiological studies
